| Ytd | 60.47% | |
| 1y | 202.80% |
| Open | 34.65 | Prev Close | 34.96 | Low | 34.55 | High | 35.13 | Mkt Cap | 25.15B |
| Vol | 1.04M | Avg Vol | 6.00M | EPS | -0.97 | P/E | -35.93 | Forward P/E | -23.07 |
| Beta | 1.11 | Short Ratio | 5.42 | Inst. Own | 76.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 31.70 | 200-d Avg | 25.69 | 1yr Est | 39.38 |
ROIV News
Roivant Sciences anticipates three commercial launches over the next few years, led by brepocitinib.
HC Wainwright sees over $1 billion in sales potential for Argenx's Vyvgart in IMNM despite myosi
Roivant Sciences Ltd. (ROIV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026
Roivant Sciences Ltd. (ROIV) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Roivant Sciences Ltd. (ROIV) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transc
Roivant (ROIV) remains a Buy as its unique 'vant' structure rapidly advances and monetizes blockbust
Roivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call Transcript
U.S. stocks halt a three-day slide as oil tumbles 5% on revived Iran truce hopes, easing inflation f
US stocks rise with Dow gaining 1% on Wednesday. The Nasdaq and S&P 500 also saw gains. Lowe'
Roivant Sciences NASDAQ: ROIV executives used the company's fourth-quarter earnings call to highligh
TAT Technologies Ltd (TATT) reported better-than-expected Q1 results, sending shares up 11.7%. Other
Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.36 per share versus the Zacks Cons
BASEL, Switzerland and LONDON and NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV)
Montes Archimedes Acquisition (ROIV) might move higher on growing optimism about its earnings prospe
Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcrip
DURHAM, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it wil
BASEL, Switzerland and LONDON and NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV)
I believe my original bull case on Roivant Sciences has largely played out, with the stock up sharpl
Roivant Sciences Ltd. (NASDAQ: ROIV - Get Free Report) has earned a consensus recommendation of "Mod
Elevate Capital Advisors LLC cut its stake in shares of Roivant Sciences Ltd. (NASDAQ: ROIV) by 31.8
Montes Archimedes Acquisition (ROIV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing
Capricorn Fund Managers Ltd raised its stake in Roivant Sciences Ltd. (NASDAQ: ROIV) by 124.4% durin
Roivant Sciences (NASDAQ: ROIV) outlined plans to expand development of its JAK1/TYK2 inhibitor brep
Roivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data
U.S. stocks were higher, with the Dow Jones index gaining more than 700 points on Friday.
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings f
On Wednesday, 807 companies reached new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.